Member Info for Bladey

Somebody mentioned News coverage by BBC on tv tonight, anyone have anymore details with regards?

That's because the World was looking for a global test for the pandemic... Every covid involved stock shot up AVCT went over £2.20 iirc... and NYCT went to £12++++!!!!

Covid test was different... firstly there were numerous UK based companies out there racing to make the first Covid test, GDR's was comparatively more expensive and to make matters worse, UK Govt., corrupt as they are were looking and buying cheaper useless quick tests outside the UK.

THIS is different... it's a UK company offering a test not available anywhere in the world using GDR patented tech... THAT's the difference!

Only 7 trading days before NICE evaluation results.. Think i'll wait till then!

Last 2 days massive volume has really shifted distressed sellers shares! Volume will get a little lighter from here on in, so any welcomed plan from BoD would really make a difference or even director buys shows they feel this is undervalued as I do!

The above will re-ignite interest and rid seller completely!...and then we're free!

https://www.nice.org.uk/news/article/nice-recommends-genetic-test-to-prevent-newborn-babies-going-deaf?utm_medium=social&utm_source=twitter&utm_campaign=genedrive_consultation_090223&utm_term=news&utm_content=thread

@guy-incognito, ok so pre-prescription of aminoglycoside antibiotics in emergency care! That's still a massive worldwide market!

..and furthermore wouldn't have it been easier for you to say that in your post? ffs

@guy_incognito... What do u mean, "No they won't", Of course they will! If adopted it will become like having the MMR vaccine.

The new genedrive kit analyses a sample taken from inside the baby's cheek. Tests at two neonatal intensive care units in Manchester and Liverpool showed it could spot who was susceptible to hearing loss in 26 minutes, and using it did not delay treatment.

This will save the NHS £65,000/patient to diagnose for early antibiotic treatment before the debilitation reaches a point of no return.. i/e the child will have irreversible hearing loss.

Which means EVERY new born baby will undergo this test!!! to eliminate any chance of this illness by early treatment through anti-biotics! That's huge IMO

FROM RNS:

NICE's final guidance on the Genedrive® MT-RNR1 ID Kit will follow a public consultation period which opens today, 9 February and closes on 21 February 2023. The final recommendations will be the basis for NICE's early value guidance on using the Genedrive® MT-RNR1 test in NHS England alongside additional data generation.

There is no current early diagnosis test apart from Genedrive test, which would save NHS considerable money on implementation into NHS and any other system. So waiting for Feb 21st to see result, more than likely this will be highly adopted!

https://www.bbc.co.uk/news/health-64570089

I like this bit:
"The NICE recommendations apply directly to England and Wales, but are often adopted more widely."

Finally some excellent news for this company!

Wow.. some big stocks quantity being bought....gotta be some pipeline news ... Churn today is amazing!

Wow, dumped 3.3% yesterday... so today and tomorrow should have Miton gone!

5p paid... for 100K no stopping this now

*definitely

Someone most definetly takeing large amount of stock here... but who?

They need to sit down...analyse and completely re-approach the well from a completely different angle to rid it of water problems. I thought they had a £60M draw down, is it not possible to use or is that for advanced stages only?

So much liquidity in this stock, many have bought to sell on news. This is a longer term hold to production as there are more drills and expenditure to come. IF this was a production well, different story and as stand-alone would not be commercial imo, but a few of these in the bag would be commercial. Next drill will target better position as ascertained from this exploratory drill.

It's not a production well, it was a exploratory drill, so they've got more drilling to do and expenditure before any profits.